$ADMA A few quotes from the recent COVID study: “It describes the largest cohort of COVID-19 patients treated with convalescent plasma thus far worldwide.” “Survival - As of 1 May 2020, 12.8% of plasma recipients and 24.4% of the 1:4 matched control patients had died….” “Interestingly, these data suggest that the survival effect of convalescent plasma may begin to manifest more than 1 week after transfusion. If this observation is borne out in subsequent studies, it could indicate that convalescent plasma prevents longer-term complications, such as acute lung injury or multi-organ dysfunction syndrome; however, this speculation awaits confirmation in a larger patient cohort.”
  • 6